CpG-ODN

COMBINATION_PRODUCT2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Second Affiliated Hospital of Guangzhou Medical University

Conditions

GlioblastomaHepatocellular CarcinomaLung CancerSolid Tumor

Phase 1

Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors

RecruitingNCT04952272

Second Affiliated Hospital of Guangzhou Medical UniversityHepatocellular Carcinoma, Lung Cancer, Solid Tumor

Start: 2021-03-01End: 2036-06-30Target: 50Updated: 2024-06-26

Phase 2

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

CompletedNCT00190424

Assistance Publique - Hôpitaux de ParisGlioblastoma

Start: 2005-09-30End: 2010-10-31Updated: 2012-12-13